Several changes have already been made to the way health technology assessments (HTAs) are conducted by NICE, the body that makes recommendations around which drugs should be reimbursed on the National Health Service (NHS) in England and Wales.
The organization’s new proportionate approach to HTAs, a program that it has dubbed PATT (proportionate approach to technology appraisals), was...







